Does Rallies show 13F holders for COR?

Yes. Rallies tracks hedge fund and 13F ownership data for COR, including fund names, share counts, latest tracked quarter, and position changes when available.

Is COR research on Rallies investment advice?

No. Rallies provides research, data, and educational context for COR. It does not provide personalized investment advice.

COR (Cencora, Inc.) Stock Analysis - Hedge Fund Holdings

Cencora, Inc. (COR) is a publicly traded Healthcare sector company. As of May 21, 2026, COR trades at $262.65 with a market cap of $50.95B and a P/E ratio of 20.19. COR moved -0.54% today. Year to date, COR is -22.34%; over the trailing twelve months it is -9.62%. Its 52-week range spans $218.65 to $377.54. Analyst consensus is strong buy with an average price target of $358.40. Rallies surfaces COR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns COR stock?

Hedge funds tracked by Rallies that own COR include Viking Global, Centerbook Partners, Bridgewater Associates, Eisler Capital, and Mangrove Partners. The latest tracked quarter is Sep 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Cencora, Inc..

COR Key Metrics

Key financial metrics for COR
Metric	Value
Price	$262.65
Market Cap	$50.95B
P/E Ratio	20.19
EPS	$13.12
Dividend Yield	0.60%
52-Week High	$377.54
52-Week Low	$218.65
Volume	1.65M
Avg Volume	0
Revenue (TTM)	$328.68B
Net Income	$2.55B
Gross Margin	3.81%

Top Hedge Funds Holding COR

Viking Global holds 1.78M shares of COR, changed -14.58% as of Sep 30, 2025.
Centerbook Partners holds 19.41K shares of COR, changed +151.30% as of Mar 31, 2026.
Bridgewater Associates holds 14.23K shares of COR, changed -43.51% as of Mar 31, 2026.
Eisler Capital holds 10.23K shares of COR, changed +0.00% as of Mar 31, 2024.
Mangrove Partners holds 2.84K shares of COR, changed +0.00% as of Sep 30, 2025.

Latest COR News

Cencora slides as Q2 adjusted EPS and cash flow miss overshadow raised outlook — May 6, 2026
Cencora drops as Walgreens early-settles forward trades and sells COR shares — Apr 21, 2026
McKesson EPS up 19.6% Drives 144% Return, Shifts Focus to Oncology — Apr 20, 2026
Cencora drops 3% as opioid-settlement costs and profit-taking pressure shares — Apr 10, 2026
Cencora to Acquire EyeSouth Partners' Retina Business for $1.1 Billion — Mar 23, 2026

Recent COR Insider Trades

Mauch Robert P. sold 3.76K (~$1.35M) on Feb 20, 2026.
Mauch Robert P. sold 1.33K (~$479.16K) on Feb 18, 2026.
Mauch Robert P. sold 5.10K (~$1.81M) on Jan 20, 2026.

COR Analyst Consensus

11 analysts cover COR: 0 strong buy, 9 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $358.40.

Common questions about COR

Who owns COR stock?: Hedge funds tracked by Rallies that own COR include Viking Global, Centerbook Partners, Bridgewater Associates, Eisler Capital, and Mangrove Partners. The latest tracked quarter is Sep 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Cencora, Inc..
Does Rallies show 13F holders for COR?: Yes. Rallies tracks hedge fund and 13F ownership data for COR, including fund names, share counts, latest tracked quarter, and position changes when available.
Is COR research on Rallies investment advice?: No. Rallies provides research, data, and educational context for COR. It does not provide personalized investment advice.